The Senate Health, Education, Labor and Pensions Committee today held a hearing for Alex Azar, President Trump’s nominee for secretary of Health and Human Services. Azar, former president of Lilly USA and deputy HHS secretary under the George W. Bush administration, faced a number of questions from senators about his ties to the pharmaceutical industry and how he would tackle high drug prices. “I believe I can bring the skills and experiences to the table that can help us address these issues, while still encouraging discovery so Americans have access to high quality care,” Azar said. Trump nominated Azar for HHS secretary earlier this month. Tom Price, M.D., resigned as HHS secretary on Sept. 29. Deputy Secretary Eric Hargan has been serving as acting secretary. Azar will need to testify before the Senate Finance Committee, which has not announced a hearing date, before the full Senate votes on his appointment.

Related News Articles

Blog
My paternal grandmother was born in 1913 as the youngest of five children and the only girl. She had three sons and no daughters. When I arrived, I was the…
Blog
I was raised by my mother, who was a nurse, and an elder sister, who both prioritized education. During a visit to Kentucky State University, I was inspired to…
Chairperson's File
Communication. Teamwork. Unity. That’s what helps drive health care innovation, accelerates health equity, improves health outcomes and advances health in our…
Headline
Fred Hobby, former president and CEO of the Institute for Diversity in Health Management, shares his thoughts on the current state of health equity efforts and…
Blog
I never drew out a map that ended with me being a hospital CEO, but I’m so humbled and blessed to have the opportunity to serve as the CEO of Sinai Chicago,…
Blog
In my 22 years at Endeavor Health, my role has been enriching and full of opportunities for personal and professional growth. There were challenges along the…